Federal AIDS Clinical Trials Group programme criticised Newsletter Article 17 February 2013 Pages: 2 - 2
Fluoxetine treatment may stop - but the metabolite lingers on Newsletter Article 17 February 2013 Pages: 2 - 3
The time has not yet come for general use of neoadjuvant therapy Newsletter Article 17 February 2013 Pages: 3 - 3
Health care databases have an important role in treatment choices Newsletter Article 17 February 2013 Pages: 3 - 3
MAb 265/F4 on the attack against multiple drug-resistant cells Newsletter Article 17 February 2013 Pages: 4 - 4
Leumedins - the new light in anti-inflammatory therapy Newsletter Article 17 February 2013 Pages: 4 - 4
SmithKline Beecham’s BRL-26830A may increase weight loss … but causes tremor Newsletter Article 17 February 2013 Pages: 5 - 5
Is it ethical to bring economics into treatment decisions? Newsletter Article 17 February 2013 Pages: 5 - 5
Patients won’t be losing their hair with this cost-effective antineoplastic regimen! Newsletter Article 17 February 2013 Pages: 5 - 6
Health care costs are cut with the Respi-Care programme Newsletter Article 17 February 2013 Pages: 6 - 6
M-CSF + antifungal therapy in immunocompromised patients with invasive fungal disease Newsletter Article 17 February 2013 Pages: 7 - 8
Surrey scientists design life saving clotbuster medicine Newsletter Article 17 February 2013 Pages: 8 - 8
Surgery does not adversely affect social outcome in epilepsy Newsletter Article 17 February 2013 Pages: 8 - 8
Management of ADHD - acceptability improves with knowledge Newsletter Article 17 February 2013 Pages: 8 - 8
Improvements in anthracycline-induced cardiac toxicity are only temporary Newsletter Article 17 February 2013 Pages: 10 - 10
Addressing the issues of metabolic control in diabetes during pregnancy Newsletter Article 17 February 2013 Pages: 10 - 10
Carrageenan - potential therapeutic use in hepatitis A Newsletter Article 17 February 2013 Pages: 10 - 11
Prednisolone pretreatment may increase response rates to ‘Intron-A’ in non-A, non-B hepatitis Newsletter Article 17 February 2013 Pages: 11 - 11
A viable treatment programme for postraumatic stress disorder Newsletter Article 17 February 2013 Pages: 11 - 11
Beware! Steroids may exacerbate the natural course of immune-mediated diseases … Newsletter Article 17 February 2013 Pages: 12 - 12
Experts endorse combination therapy for severe asthma attacks Newsletter Article 17 February 2013 Pages: 13 - 13
Morphine tablets are acceptable for most patients with severe cancer pain Newsletter Article 17 February 2013 Pages: 14 - 14
Surfactant therapy improves the survival of ELBW premature neonates… Newsletter Article 17 February 2013 Pages: 14 - 14
Troleandomycin alone controls a case of steroid-dependent asthma Newsletter Article 17 February 2013 Pages: 15 - 15
Sublingual ketanserin reduces BP more effectively than oral administration Newsletter Article 17 February 2013 Pages: 15 - 15
Ganciclovir + IVIG resolves CMV infection during mechanical ventilation… Newsletter Article 17 February 2013 Pages: 16 - 16
…and IVIG is a possible alternative to plasma exchange in myasthenia gravis Newsletter Article 17 February 2013 Pages: 16 - 16
Marine oil capsules have a role in the treatment of hyperlipidaemia … Newsletter Article 17 February 2013 Pages: 16 - 17
Selegiline improves behaviour in Alzheimer’s disease without sedation … Newsletter Article 17 February 2013 Pages: 17 - 17
…and ACE inhibitors may have a new use in Alzheimer’s disease Newsletter Article 17 February 2013 Pages: 17 - 17
Heparin may slow progression of renal dysfunction in diabetic nephropathy … Newsletter Article 17 February 2013 Pages: 18 - 18
… urokinase preserves renal function in diabetic nephropathy … Newsletter Article 17 February 2013 Pages: 18 - 18
…and camostat may be effective in diabetic nephropathy Newsletter Article 17 February 2013 Pages: 18 - 18